1. Home
  2. XOMAP vs RILYP Comparison

XOMAP vs RILYP Comparison

Compare XOMAP & RILYP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo XOMA Corporation 8.625% Series A Cumulative Perpetual Preferred Stock

XOMAP

XOMA Corporation 8.625% Series A Cumulative Perpetual Preferred Stock

N/A

Current Price

$26.68

Market Cap

0.0

Sector

Health Care

ML Signal

N/A

Logo B. Riley Financial Inc.

RILYP

B. Riley Financial Inc.

N/A

Current Price

$3.95

Market Cap

0.0

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
XOMAP
RILYP
Founded
N/A
1973
Country
United States
United States
Employees
13
2056
Industry
Biotechnology: Pharmaceutical Preparations
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
N/A
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
XOMAP
RILYP
Price
$26.68
$3.95
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
N/A
38.1K
Earning Date
N/A
01-01-0001
Dividend Yield
N/A
7.03%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$854,383,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
N/A
$1.73
52 Week High
N/A
$20.00

Technical Indicators

Market Signals
Indicator
XOMAP
RILYP
Relative Strength Index (RSI) 57.24 28.93
Support Level $26.38 $3.74
Resistance Level $26.62 $4.48
Average True Range (ATR) 0.09 0.36
MACD 0.02 -0.05
Stochastic Oscillator 100.00 11.83

Price Performance

Historical Comparison
XOMAP
RILYP

About XOMAP XOMA Corporation 8.625% Series A Cumulative Perpetual Preferred Stock

XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Geographically, the company operates in Switzerland, United States, Asia Pacific, Europe and Others.

About RILYP B. Riley Financial Inc.

B. Riley Financial Inc is a diversified financial services company. The company through its subsidiaries offers investment banking and financial services to corporate, institutional, and high-net-worth clients and also asset disposition, valuation and appraisal, and capital advisory services to retail, wholesale, institutional, lenders, capital providers, private equity investors, and professional services firms in United States, Canada, and Europe. It also provides internet access and subscription services. The reportable operating segments of the company include Capital Markets, Wealth Management, Financial Consulting, Auction and Liquidation, Communications segment, and Consumer products segment.

Share on Social Networks: